Wall Street Journal Pro
New Venture Fund Targets Innovations in Blood Research
New York Blood Center, other healthcare nonprofits are using venture capital to help startups tackle diseases
On Thursday, May 11, Wall Street Journal featured the article, “New Venture Fund Targets Innovations in Blood Research,” highlighting the work of New York Blood Center, and other healthcare nonprofits, to utilize venture capital to help startups treat diseases.
The article elaborates on NYBC’s venture fund designed to invest in startups targeting conditions that do not typically garner investor attention and details how NYBC is one of several healthcare nonprofits to form venture groups to foster innovation. As NYBCe President and CEO Christopher D. Hillyer, MD, explained, the venture team’s goal is “finding startups that not only have a humanitarian ROI, but a fiscal ROI for our blood center.”